Dendritic Cell Density and Activation in Breast Cancer
Author Information
Author(s): Coventry B J, Lee P-L, Gibbs D, Hart D N J
Primary Institution: University of Adelaide
Hypothesis
The study investigates the expression of dendritic cell markers in human breast cancer to assess their activation state.
Conclusion
The study found that both dendritic cell numbers and activation are significantly deficient in human breast cancers.
Supporting Evidence
- Few or no CD1a-positive dendritic cells were found in the breast cancer samples.
- Minimal expression of dendritic cell activation markers was observed.
- Dendritic cell numbers and activation were found to be deficient regardless of tumor grade.
Takeaway
The study shows that there aren't enough active dendritic cells in breast cancer, which might be why the immune system doesn't fight the cancer well.
Methodology
The study used immunohistochemical techniques to assess the density and activation of dendritic cells in breast cancer tissues.
Limitations
The study may have limitations in accurately counting dendritic cells due to their low numbers and potential background staining.
Participant Demographics
The study included 40 human breast cancer samples of varying histological grades.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website